Technology News and Research

RSS

Crescendo Biologics raises funds to advance the development of its fragment antibody technology platforms

Crescendo Biologics today announces it has raised GBP4.5 million in a seed-funding round to advance the development of its fragment antibody technology platforms. The funding round was led by Sofinnova Partners, a Paris-based venture capital firm, with Aitua, Avlar BioVentures and the Rainbow Seed Fund also participating.

12 Oct 2009

Concord Coalition sends list of suggestions concerning the healthcare reform bill

In the coming days, you have the unenviable task of combining the Senate Finance Committee's health care reform bill with the bill that emerged from the Health, Education, Labor and Pensions Committee. Aware of the difficulty and the competing pressures you face, we have identified in the attached memorandum key areas where we believe the potential of the legislation to produce fiscal gains can be strengthened. We hope our views will help guide your work -- consistent with fiscal responsibility and sustainability.

12 Oct 2009

New technique may lead to more effective treatment for liver disease

A combination of bioengineering and medical research at the University of California, San Diego has led to a new discovery that could pave the way for more effective treatments for liver disease.

12 Oct 2009

InfoLogix retains SSG Capital Advisors as its investment banker

InfoLogix, Inc., a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, today announced that it has retained SSG Capital Advisors, LLC, a nationally recognized investment bank based in West Conshohocken, PA to assist InfoLogix in exploring its private placement alternatives.

12 Oct 2009

Arch Pharmalabs collaborates with Orochem Technologies to manufacture an API in India

Arch Pharmalabs, Ltd., a leading provider of small molecule process R&D and full life-cycle custom synthesis and manufacturing services, announced today it has entered into a strategic partnership with Orochem Technologies, Inc., to manufacture a U.S. innovator’s active pharmaceutical ingredient (API) in late-stage clinical development using Simulated Moving Bed (SMB) technology.

12 Oct 2009

Merial to expand its plant in China

Merial, the Animal Health division of the sanofi-aventis Group, announced today that Merial Animal Health Co. (China) held a ground-breaking ceremony for an expansion project at its plant located in the Nanchang Hi-tech Development Zone, China. Merial Animal Health Co. (China), a venture of Merial Limited and the Group's first production facility in China has been in operation for almost 20 years.

12 Oct 2009

Phase I clinical trial results for Fentanyl Lauriad announced by BioAlliance Pharma

BioAlliance Pharma SA (Euronext Paris – BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announced the approval from the French Drug Agency (AFSSaPS) to enter first Phase I clinical trial for Fentanyl Lauriad®.

12 Oct 2009

Hyper-SAGE with MRI sensitivity, a promising tool for in vivo diagnostics and molecular imaging

A new technique in Magnetic Resonance Imaging dubbed "Hyper-SAGE" has the potential to detect ultra low concentrations of clincal targets, such as lung and other cancers. Development of Hyper-SAGE was led by one of the world's foremost authorities on MRI technology, Alexander Pines, a chemist who holds joint appointments with the Lawrence Berkeley National Laboratory (Berkeley Lab) and the University of California, Berkeley.

12 Oct 2009

Locus Pharmaceuticals enters into discovery research collaboration with Novartis

Locus Pharmaceuticals announced today that it has entered into a discovery research collaboration with Novartis. Locus will collaborate with Novartis to discover novel chemotypes on targets of interest to Novartis’ select therapeutic areas.

12 Oct 2009

Canary Foundation to implement biosensor technologies for early cancer detection

Canary Foundation has committed to being the first organization to implement the breakthrough in biosensor technologies in its research pipeline. The new technology promises to revolutionize the early detection cancer field.

12 Oct 2009

World’s first engineered T cell receptor trial opens with new cellular therapy for HIV

Researchers at Adaptimmune Limited and the University of Pennsylvania School of Medicine, have announced the approval of an Investigational New Drug (IND) application from the US Food and Drug Administration (FDA) and opening for enrolment of the first ever study using patients’ cells carrying an engineered T cell receptor to treat HIV (SL9 HA-GAG-TCR). The trial may have important implications in the development of new treatments for HIV potentially slowing – or even preventing – the onset of AIDS.

11 Oct 2009

The 'Turbocharged' health IT industry

Allscripts, the Chicago-based electronic medical records company, has more than doubled its profits since last year, Forbes reports in a special report. Its stock doubled, too, and it attracted nearly 50 percent more business. It's been a "sweet year" for Glen Tullman, the company's chief. That's due in part to a $19 billion infusion into the health information technology industry from the federal stimulus package.

9 Oct 2009

PFCD releases the updated comparison of chronic care provisions contained within health reform bill

The Partnership to Fight Chronic Disease (PFCD) today released an updated comparison of chronic care provisions contained within health reform legislation to reflect the amended Senate Finance Committee proposal. The amended "Chairman's Mark" includes numerous provisions to prevent and manage chronic disease, the top cost driver in health care, as do the two other major pieces of health reform legislation under consideration in Congress.

9 Oct 2009

Agriculture investment in developing countries must increase by 50% to feed 9.1B people by 2050, FAO report says

Developing countries need agriculture investments of $83 billion per year to meet the food needs of a projected

9 Oct 2009

Health Discovery retains Dilenschneider Group to manage its investor and media relations work

Health Discovery Corporation, is pleased to announce that it has retained The Dilenschneider Group, headquartered in New York City, to manage the Company’s investor and media relations work. With offices in New York, Washington, DC and Chicago, the Dilenschneider Group provides its clients with some of the finest and most seasoned communications professionals in the world.

9 Oct 2009

Aperio's new digital slide sharing service for pathology incorporated as part of CAP’s Diagnostic Work Station

Aperio Technologies, Inc., a global leader in digital pathology for the healthcare and life sciences industry is pleased to announce that SecondSlide™, its newly launched digital slide sharing service for pathology, has been incorporated as one of the vendor solutions in the College of American Pathologists (CAP) prototype of the Diagnostic Work Station (DWS), a collaborative and heterogeneous vendor-neutral environment.

9 Oct 2009

Kimberly-Clark to acquire I-Flow Corporation

Kimberly-Clark Corporation and I-Flow Corporation, a leading healthcare company that develops and markets technically advanced, low-cost drug delivery systems and innovative products for post-surgical pain relief and surgical site care, today announced a definitive agreement whereby I-Flow will be acquired in a cash tender offer for approximately $324 million on a fully diluted basis.

9 Oct 2009

LeVOCC air purification system destroys the PR8 strain of the H1N1 virus

LeVOCC, Inc. today announced that independent laboratory testing has conclusively demonstrated that the LeVOCCTM air purification system successfully destroys a strain of the H1N1 virus. Testing was conducted using the Puerto Rico 8 (PR8) strain of the H1N1 virus. This strain is an influenza A H1N1 seasonal strain and is a valid representative of all H1N1 strains.

9 Oct 2009

Courtyard Group commends Auditor General's report on eHealth initiative

Courtyard Group today responded after reviewing details of the Ontario Auditor General's report on the eHealth initiative.

9 Oct 2009

Government of Quebec develops new strategy to strengthen biopharmaceutical sectors

In the midst of challenging economic times, the announcement of the Quebec government's biopharmaceutical strategy is good news for basic pharmaceutical research and patient access to innovative medicines, said Dawn Graham, President of Merck Frosst Canada today in response to the release of the Quebec Pharmaceutical Strategy.

9 Oct 2009

Technology News and Research

Crescendo Biologics raises funds to advance the development of its fragment antibody technology platforms

Concord Coalition sends list of suggestions concerning the healthcare reform bill

New technique may lead to more effective treatment for liver disease

InfoLogix retains SSG Capital Advisors as its investment banker

Arch Pharmalabs collaborates with Orochem Technologies to manufacture an API in India

Merial to expand its plant in China

Phase I clinical trial results for Fentanyl Lauriad announced by BioAlliance Pharma

Hyper-SAGE with MRI sensitivity, a promising tool for in vivo diagnostics and molecular imaging

Locus Pharmaceuticals enters into discovery research collaboration with Novartis

Canary Foundation to implement biosensor technologies for early cancer detection

World’s first engineered T cell receptor trial opens with new cellular therapy for HIV

The 'Turbocharged' health IT industry

PFCD releases the updated comparison of chronic care provisions contained within health reform bill

Agriculture investment in developing countries must increase by 50% to feed 9.1B people by 2050, FAO report says

Health Discovery retains Dilenschneider Group to manage its investor and media relations work

Aperio's new digital slide sharing service for pathology incorporated as part of CAP’s Diagnostic Work Station

Kimberly-Clark to acquire I-Flow Corporation

LeVOCC air purification system destroys the PR8 strain of the H1N1 virus

Courtyard Group commends Auditor General's report on eHealth initiative

Government of Quebec develops new strategy to strengthen biopharmaceutical sectors

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News